Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: Two case reports

International Journal of Hematology

Volumn 91, Issue 5, 2010, Pages 844-849

  Yoshida, Tatsuya ^a   Kusumoto, Shigeru ^a   Inagaki, Atsushi ^a   Mori, Fumiko ^a   Ito, Asahi ^a   Ri, Masaki ^a   Ishida, Takashi ^a   Komatsu, Hirokazu ^a   Iida, Shinsuke ^a   Sugauchi, Fuminaka ^a   Tanaka, Yasuhito ^a   Mizokami, Masashi ^b   Ueda, Ryuzo ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Japan Konodai Hospital   (Japan)

Author keywords

HBV; Myeloma; Reactivation; Transplantation

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; MELPHALAN; PREDNISOLONE; RANIMUSTINE; VINCRISTINE; VIRUS DNA; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; FEMALE; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PATIENT MONITORING; VIRUS REACTIVATION; ALLOTRANSPLANTATION; CASE REPORT; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; VIROLOGY; VIRUS ACTIVATION;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEXAMETHASONE; DOXORUBICIN; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; PREDNISOLONE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; VINCRISTINE; VIRUS ACTIVATION;

EID: 77954533430     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0592-y     Document Type: Article

References (16)

1. AS Lok RH Liang EK Chiu KL Wong TK Chan D Todd 1991 Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study Gastroenterology 100 182 188 1:STN:280: DyaK3M%2FmtVSiuw%3D%3D 1983820
2. I Dervite D Hober P Morel 2001 Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab N Engl J Med 344 68 69 10.1056/NEJM200101043440120 1:STN:280:DC%2BD3M%2Fnt1Sgug%3D%3D 11187122
3. CK Hui WW Cheung HY Zhang WY Au YH Yueng AY Leung, et al. 2006 Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy Gastroenterology 131 59 68 10.1053/j.gastro.2006.04.015 1:CAS:528:DC%2BD28XnvF2gsL0%3D 16831590
4. W Yeo TC Chan NW Leung WY Lam FK Mo MT Chu, et al. 2009 Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab J Clin Oncol 27 605 611 10.1200/JCO.2008.18.0182 1:CAS:528:DC%2BD1MXivFyju7s%3D 19075267
5. S Kusumoto Y Tanaka M Mizokami R Ueda 2009 Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma Int J Hematol 90 13 23 10.1007/s12185-009-0359-5 1:CAS:528:DC%2BD1MXotV2qt7o%3D 19544079
6. M Sugiyama Y Tanaka F Kurbanov I Maruyama T Shimada S Takahashi, et al. 2009 Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes Gastroenterology 136 652 662 10.1053/j.gastro.2008.10.048 1:CAS:528:DC%2BD1MXislOhtbs%3D 19041311
7. T Endo K Sawada K Fujimoto S Yamamoto H Takashima Y Haseyama, et al. 2000 Reactivation of hepatitis B virus after autologous peripheral blood stem cell transplantation in patients with positive hepatitis B surface antibodies Rinsho Ketsueki 41 322 328 1:STN:280:DC%2BD3czovVSgsg%3D%3D 10846463
8. JE Uhm K Kim TK Lim BB Park S Park YS Hong, et al. 2007 Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation Biol Blood Marrow Transplant 13 463 468 10.1016/j.bbmt.2006.11. 019 1:CAS:528:DC%2BD2sXkslWitrw%3D 17382252 (Pubitemid 46421889)
9. K Kumagai T Takagi S Nakamura U Sawada Y Kura F Kodama, et al. 1997 Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan Ann Oncol 8 Suppl 1 107 109 10.1023/A: 1008234807768 9187442
10. JF San Miguel R Schlag NK Khuageva MA Dimopoulos O Shpilberg M Kropff, et al. 2008 Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma N Engl J Med 359 906 917 10.1056/NEJMoa0801479 1:CAS:528:DC%2BD1cXhtVGms77K 18753647
11. T Facon JY Mary C Hulin L Benboubker M Attal B Pegourie, et al. 2007 Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial Lancet 370 1209 1218 10.1016/S0140-6736(07)61537-2 1:CAS:528:DC%2BD2sXhtFehsr%2FN 17920916 (Pubitemid 47516593)
12. M Dimopoulos A Spencer M Attal HM Prince JL Harousseau A Dmoszynska, et al. 2007 Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma N Engl J Med 357 2123 2132 10.1056/NEJMoa070594 1:CAS:528: DC%2BD2sXhtlGis7nN 18032762 (Pubitemid 350146107)
13. CM Weinbaum I Williams EE Mast SA Wang L Finelli A Wasley, et al. 2008 Recommendations for identification and public health management of persons with chronic hepatitis B virus infection MMWR Recomm Rep 57 1 20 18802412
14. E Tanaka T Umemura 2008 History and prevention of de novo hepatitis B virus-related hepatitis in Japan and the world Clin J Gastroenterol 1 83 86 10.1007/s12328-008-0030-3
15. AS Lok BJ McMahon 2009 Chronic hepatitis B: update 2009 Hepatology 50 661 662 10.1002/hep.23190 19714720
16. N Fukushima T Mizuta M Tanaka M Yokoo M Ide T Hisatomi, et al. 2009 Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier Ann Oncol 20 2013 2017 10.1093/annonc/mdp230 1:STN:280:DC%2BD1MjntFKlug%3D%3D 19561036